Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?

Glioblastoma (GBM) is the most frequent malignant primary brain tumor in adults, characterized by a highly aggressive, inflammatory and angiogenic phenotype. It is a remarkably heterogeneous tumor at several levels, including histopathologically, radiographically and genetically. The 2016 update of...

Descripción completa

Detalles Bibliográficos
Autores principales: Linhares, Paulo, Carvalho, Bruno, Vaz, Rui, Costa, Bruno M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461098/
https://www.ncbi.nlm.nih.gov/pubmed/32823572
http://dx.doi.org/10.3390/ijms21165809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461098/
https://www.ncbi.nlm.nih.gov/pubmed/32823572
http://dx.doi.org/10.3390/ijms21165809

Ejemplares similares